In a heartwarming turn of events, a couple from Singapore has harnessed the power of community support to raise over £1.4 million within just ten days for their five-month-old daughter, Ginny. This urgent fundraising effort was sparked by Ginny’s diagnosis of Spinal Muscular Atrophy (SMA), a rare genetic disorder that could jeopardise her life before she turns two.
:max_bytes(150000):strip_icc():format(jpeg)/baby-ginny-032326-f8d7e344ce7e47ffba23ea3f826bc379.jpg)
Ginny’s parents, Jenny Mak and her partner, have shared that their daughter is an inquisitive and lively child. “Ginny smiles when she sees familiar faces and recognises the voices of her loved ones. She explores the world with wide-eyed curiosity,” they expressed. However, the family’s joy has been marred by the reality of Ginny’s condition, which they first suspected after noticing her inability to hold her head up during tummy time shortly after her third month.

Spinal Muscular Atrophy is classified as a genetic neuromuscular disorder that results in muscle weakness and atrophy. In Ginny’s case, she was diagnosed with SMA type 1, the most prevalent form of the disease. As specialists from Cleveland Clinic explain, symptoms typically manifest within the baby’s first six months. The rarity of the disorder means that it affects approximately one in every 10,000 individuals, with only a handful of cases reported annually in Singapore.

Mak recounted how initial medical assessments led doctors to believe Ginny’s development was within normal ranges. Nevertheless, concerns mounted as her mobility began to decline. “Her legs barely moved, despite her being alert and responsive,” Mak reflected, showing concern as the signs of SMA began to unfold.
In January of this year, the situation worsened when Ginny was hospitalised due to pneumonia. It was at KK Women’s and Children’s Hospital that the family was given the devastating confirmation of SMA. Dr. Jocelyn Lim, who treated Ginny, outlined the grim progression of SMA type 1, highlighting that children with this condition often face challenges such as poor muscle tone, difficulties with swallowing, and frequent respiratory infections. Without treatment, many do not survive beyond the age of two.
Fortunately, there are treatments available that can increase Ginny’s chances of survival, including a gene therapy called Zolgensma and an oral medication known as Risdiplam. However, the latter is not covered in Singapore, and Zolgensma comes with a staggering price tag of over £1.4 million. Faced with this daunting financial need, Ginny’s parents sought help through the online fundraising platform, Ray of Hope, on 12 March.
The couple expressed immense gratitude towards their supporters after successfully achieving their fundraising goal. They shared an update on their campaign, stating, “When we first began this journey, we didn’t know what to expect. Many of you went above and beyond—sharing Ginny’s story, reaching out to your communities, and standing alongside us in hope. Your kindness and compassion have made a real difference and brought Ginny one step closer to receiving the treatment she urgently needs.”
As preparations for Ginny’s therapy progress, her parents are now focusing on maintaining her health ahead of the treatment. They expressed their anticipation to begin the next steps with medical professionals, stating their hope for a seamless transition into the therapy in the forthcoming weeks.
Reflecting the depth of their gratitude, Mak and her partner made sure to acknowledge their donors through social media, thanking every kind individual who contributed to Ginny’s cause. Their journey serves as both a poignant reminder of the challenges faced by families dealing with rare illnesses and the remarkable strength that communities can exhibit when faced with such a crisis.
As Ginny’s parents continue to navigate this arduous path, the overwhelming support they have received is a testament to the compassion and solidarity that can flourish in times of need. Their story not only highlights the challenges posed by SMA but also shines a light on the power of community and hope in the face of debilitating circumstances.
